{"title":"AN ACTINOMYCES ABSCESS FOLLOWING INTRAOVARIAN INJECTION OF PLATELET-RICH PLASMA (PRP): A CASE STUDY","authors":"Arife Akay , Yasin Semih Ekici , Bakiye Akbaş , Gülsün Özbay , Ayşe Zehra Özdemir , Davut Güven","doi":"10.1016/j.rbmo.2024.104591","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div><strong>The</strong> intraovarian injection of platelet-rich plasma (PRP) represents a novel approach with the potential to enhance folliculogenesis and elevate live birth rates in poor responders. Nevertheless, as with any interventional procedure, there is a possibility of adverse effects associated with the administration of PRP.</div></div><div><h3>Case Report</h3><div>A 22-year-old female patient, who had undergone intraovarian injection of PRP at another centre two weeks prior, was prescribed ciprofloxacin for the treatment of groin pain that developed one week following the procedure. The patient was admitted with a history of increasing groin pain, fever, and chills. Despite the stability of the vital signs, the patient exhibited tenderness in the lower quadrants of the abdomen. The laboratory findings indicated elevated levels of C-reactive protein (CRP), procalcitonin (PCT), and white blood cells (WBC). The computed tomography (CT) scan revealed the presence of a 7 cm tubo-ovarian abscess in the right sight. On the second day of hospitalization, the patient subsequently underwent abscess drainage in the interventional radiology department, and an abscess culture was obtained. The infectious diseases department recommended piperacillin-tazobactam 3*4.5 g IV. Subsequently, these treatments resulted in an improvement in the patient's condition and a reduction in acute-phase reactants (AFRs), with a decrease in CRP (308->92), PCT (1.8->0.69), and WBC (21.600->18.550). However, on the fifth day, the AFRs began to increase once more, piperacillin-tazobactam was discontinued following the identification of Actinomyces in the abscess culture, and ampicillin-sulbactam 4*1.5 g IV was initiated in conjunction with the gentamicin-clindamycin protocol. A clinical and laboratory evaluation conducted on the seventh day of hospitalization revealed no improvement. Following the detection of free fluid in the abdomen and persistent abscess sites via ultrasonography (Video 1), a decision was made to proceed with laparoscopic abscess drainage. An encapsulated abscess extending from the anterior surface of the uterus to the upper abdomen towards the spleen was cleaned with the contributions of the general surgery team, and a soft drain was placed laparoscopically (Figure 1). Following the procedure, a favorable response was observed in both the clinical condition and the AFR regression with the current antibiotic regimen. The patient was discharged on the 12th day with oral amoxicillin-clavulanate.</div></div><div><h3>Conclusion</h3><div>Despite the existence of ongoing randomized controlled trials evaluating the efficacy of PRP in women with poor responses, its clinical application remains considered experimental. The intraovarian injection of PRP, an invasive approach designed to enhance ovarian response, has been observed to manifest in rare instances as serious complications.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 ","pages":"Article 104591"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive biomedicine online","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1472648324007806","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
The intraovarian injection of platelet-rich plasma (PRP) represents a novel approach with the potential to enhance folliculogenesis and elevate live birth rates in poor responders. Nevertheless, as with any interventional procedure, there is a possibility of adverse effects associated with the administration of PRP.
Case Report
A 22-year-old female patient, who had undergone intraovarian injection of PRP at another centre two weeks prior, was prescribed ciprofloxacin for the treatment of groin pain that developed one week following the procedure. The patient was admitted with a history of increasing groin pain, fever, and chills. Despite the stability of the vital signs, the patient exhibited tenderness in the lower quadrants of the abdomen. The laboratory findings indicated elevated levels of C-reactive protein (CRP), procalcitonin (PCT), and white blood cells (WBC). The computed tomography (CT) scan revealed the presence of a 7 cm tubo-ovarian abscess in the right sight. On the second day of hospitalization, the patient subsequently underwent abscess drainage in the interventional radiology department, and an abscess culture was obtained. The infectious diseases department recommended piperacillin-tazobactam 3*4.5 g IV. Subsequently, these treatments resulted in an improvement in the patient's condition and a reduction in acute-phase reactants (AFRs), with a decrease in CRP (308->92), PCT (1.8->0.69), and WBC (21.600->18.550). However, on the fifth day, the AFRs began to increase once more, piperacillin-tazobactam was discontinued following the identification of Actinomyces in the abscess culture, and ampicillin-sulbactam 4*1.5 g IV was initiated in conjunction with the gentamicin-clindamycin protocol. A clinical and laboratory evaluation conducted on the seventh day of hospitalization revealed no improvement. Following the detection of free fluid in the abdomen and persistent abscess sites via ultrasonography (Video 1), a decision was made to proceed with laparoscopic abscess drainage. An encapsulated abscess extending from the anterior surface of the uterus to the upper abdomen towards the spleen was cleaned with the contributions of the general surgery team, and a soft drain was placed laparoscopically (Figure 1). Following the procedure, a favorable response was observed in both the clinical condition and the AFR regression with the current antibiotic regimen. The patient was discharged on the 12th day with oral amoxicillin-clavulanate.
Conclusion
Despite the existence of ongoing randomized controlled trials evaluating the efficacy of PRP in women with poor responses, its clinical application remains considered experimental. The intraovarian injection of PRP, an invasive approach designed to enhance ovarian response, has been observed to manifest in rare instances as serious complications.
卵巢内注射富血小板血浆(PRP)代表了一种新的方法,具有增强卵泡发生和提高不良反应患者活产率的潜力。然而,与任何介入性手术一样,PRP的使用可能会产生不良反应。病例报告:一名22岁的女性患者,两周前在另一中心接受卵巢内PRP注射,处方环丙沙星治疗手术后一周出现的腹股沟疼痛。患者入院时有腹股沟疼痛加重、发热和发冷病史。尽管生命体征稳定,患者表现出腹部下象限的压痛。实验室结果显示c反应蛋白(CRP)、降钙素原(PCT)和白细胞(WBC)水平升高。计算机断层扫描(CT)显示存在一个7厘米的输卵管卵巢脓肿在右眼。入院第2天,患者于介入放射科行脓肿引流术,并行脓肿培养。传染病科推荐使用哌拉西林-他唑巴坦3*4.5 g IV。随后,这些治疗导致患者病情改善,急性期反应物(afr)减少,CRP (308->92), PCT (1.8->0.69)和WBC (21.600->18.550)下降。然而,在第5天,afr再次开始增加,在脓肿培养中发现放线菌后停用哌拉西林-他唑巴坦,并开始使用氨苄西林-舒巴坦4*1.5 g IV,同时使用庆大霉素-克林霉素方案。在住院第7天进行的临床和实验室评估显示没有改善。通过超声检查发现腹部游离液体和持续脓肿部位(视频1),我们决定进行腹腔镜脓肿引流术。在普外科团队的帮助下,清理了从子宫前表面延伸到上腹部并朝向脾脏的包膜脓肿,并在腹腔镜下放置了软引流管(图1)。手术后,在当前抗生素方案下,临床状况和AFR消退均有良好的反应。患者于第12天出院,口服阿莫西林-克拉维酸酯。结论尽管目前仍有随机对照试验评估PRP对不良反应女性的疗效,但其临床应用仍被认为是实验性的。卵巢内注射PRP是一种旨在增强卵巢反应的侵入性方法,已观察到在极少数情况下表现为严重的并发症。
期刊介绍:
Reproductive BioMedicine Online covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients.
Context:
The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. High quality research on lower animals is included if it helps to clarify the human situation. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy.